Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

YALE UNIVERSITY

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1701-10-09

Employees: 10K

Market Cap: -

Website: http://www.yale.edu

Clinical Trials

Ranolazine and Microvascular Angina by PET in the Emergency Department

Phase 4

Completed

Conditions: Microvascular Angina

Interventions: Drug: Placebo
Drug: Ranolazine

First Posted Date: 2014-01-31

Last Posted Date: 2017-05-16

Lead Sponsor: Yale University

Target Recruit Count: 31

Registration Number: NCT02052011

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

Guanfacine Clinical Trial for Smoking Cessation

Phase 2

Completed

Conditions: Smoking Cessation

Interventions: Drug: Placebo
Drug: Guanfacine

First Posted Date: 2014-01-31

Last Posted Date: 2021-12-29

Lead Sponsor: Yale University

Target Recruit Count: 121

Registration Number: NCT02051309

Locations: 🇺🇸
Yale Center for Clinical Investigations, Yale University, New Haven, Connecticut, United States

Treatment of Hepatic Encephalopathy With Flumazenil and Change in Cortical GABA Levels in MRS

Phase 1

Withdrawn

Conditions: Hepatic Encephalopathy
Liver Cirrhosis

Interventions: Drug: Flumazenil
Drug: Placebo

First Posted Date: 2014-01-29

Last Posted Date: 2020-07-07

Lead Sponsor: Yale University

Registration Number: NCT02048969

Locations: 🇺🇸
Yale Psychological Medicine Research Center, New Haven, Connecticut, United States

Pain Management for Veterans Filing Compensation Claims

Not Applicable

Completed

Conditions: Pain

Interventions: Behavioral: SBIRT-PM
Behavioral: Pain Module

First Posted Date: 2014-01-29

Last Posted Date: 2018-06-15

Lead Sponsor: Yale University

Target Recruit Count: 120

Registration Number: NCT02049086

Locations: 🇺🇸
VA Connecticut Healthcare System (VACHS), West Haven, Connecticut, United States

Randomized Controlled Trial of Aspirin vs Placebo in the Treatment of Pre-psychosis

Early Phase 1

Terminated

Conditions: Clinical High Risk for Psychosis

Interventions: Drug: Aspirin
Drug: Placebo

First Posted Date: 2014-01-28

Last Posted Date: 2021-05-17

Lead Sponsor: Yale University

Target Recruit Count: 1

Registration Number: NCT02047539

Locations: 🇺🇸
PRIME Research Clinic, New Haven, Connecticut, United States

Combination Chemotherapy Before and After Surgery in Treating Patients With Localized Pancreatic Cancer

Phase 2

Active, not recruiting

Conditions: Stage I Pancreatic Cancer
Stage IIB Pancreatic Cancer
Acinar Cell Adenocarcinoma of the Pancreas
Stage IIA Pancreatic Cancer
Duct Cell Adenocarcinoma of the Pancreas

Interventions: Drug: oxaliplatin
Drug: leucovorin calcium
Drug: irinotecan hydrochloride
Drug: fluorouracil
Procedure: therapeutic conventional surgery
Other: laboratory biomarker analysis

First Posted Date: 2014-01-28

Last Posted Date: 2023-11-13

Lead Sponsor: Yale University

Target Recruit Count: 46

Registration Number: NCT02047474

Locations: 🇺🇸
Smilow Cancer Hospital at St. Francis Hospital, Hartford, Connecticut, United States
🇺🇸
Smilow Cancer Hospital at North Haven, North Haven, Connecticut, United States
🇺🇸
Yale University, New Haven, Connecticut, United States

and more 6 locations

Atomoxetine's Effects On Nicotine Response And Stress Response In Smokers

Phase 1

Withdrawn

Conditions: Nicotine Dependence

Interventions: Drug: Placebo
Drug: Atomoxetine

First Posted Date: 2014-01-27

Last Posted Date: 2017-05-22

Lead Sponsor: Yale University

Registration Number: NCT02046551

Locations: 🇺🇸
West Haven Veterans Affairs, West Haven, Connecticut, United States

A Prospective Trial to Reduce Post-Operative Pain in Implant Based Breast Reconstruction

Phase 2

Terminated

Conditions: Post-operative Pain

Interventions: Drug: Analgesics
Drug: Bupivacaine
Drug: Botulinum Toxins

First Posted Date: 2014-01-23

Last Posted Date: 2017-04-10

Lead Sponsor: Yale University

Target Recruit Count: 2

Registration Number: NCT02044302

Locations: 🇺🇸
Yale New Haven Hospital, New Haven, Connecticut, United States

CBT for Spanish Speakers

Not Applicable

Completed

Conditions: Substance Use

Interventions: Behavioral: Standard Treatment as Usual
Behavioral: CBT4CBT plus Standard treatment as usual

First Posted Date: 2014-01-23

Last Posted Date: 2020-03-06

Lead Sponsor: Yale University

Target Recruit Count: 99

Registration Number: NCT02043210

Locations: 🇺🇸
Hispanic Clinic, New Haven, Connecticut, United States
🇺🇸
Fair Haven Community Health, New Haven, Connecticut, United States
🇺🇸
MAAS, New Haven, Connecticut, United States

and more 1 locations

Study to Evaluate the Health and Wellness Policies of the New Haven Public School District.

Not Applicable

Completed

Conditions: Obesity
Chronic Diseases

Interventions: Other: DISTRICT WELLNESS COMMITTEE
Other: NUTRITIONAL QUALITY OF FOODS AND BEVERAGES ON CAMPUS
Other: HEALTH PROMOTION AND MARKETING
Other: OPPORTUNITIES FOR PHYSICAL ACTIVITY

First Posted Date: 2014-01-23

Last Posted Date: 2018-01-17

Lead Sponsor: Yale University

Target Recruit Count: 796

Registration Number: NCT02043626

Locations: 🇺🇸
Yale University, New Haven, Connecticut, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy